New England Business and Technology Association to Host ''The New Biotech/Pharma Research Organization'' As Part of Association's Pipeline Series.
WHAT: The New England Business and Technology Association (NEBATA) announces that it will host an interactive panel discussion entitled "The New Biotech/Pharma Research Organization" as part of the Association's Pipeline Series. The session will be held on Tuesday, November 9, 2004 at Wilmer Cutler Pickering Hale and Dorr, LLP, 60 State Street, Boston, MA. "The New Biotech/Pharma Research Organization" will focus on addressing key issues and questions that arise for biotechnology and pharmaceutical companies such as: -- What is the "future state" of research and discovery? What will winning companies do differently in one, three, five and ten years? -- What is driving companies toward that "future state?" How can the great goal of "getting more for less" be a realized? How will companies be able to get more drugs approved per each investment dollar? -- What will winning companies do from a technology point of view to reach this end point faster and more efficiently? How will companies be able to get "spend" aligned with company strategies and goals? WHO: Confirmed participants include: Brock Reeve, Vice President, Consulting Practice - Life Science Insights (moderator) Rainer Fuchs PhD, Vice President, Research Informatics - Biogen Idec, Inc. Andy Palmer, CIO & Senior Vice President, Operations - Infinity Pharmaceuticals Ellen Ridge, Vice President - Genzyme Corporation David Yee, Head of Knowledge and Information Systems - Archemix WHEN: Tuesday, November 9, 2004 7:30 a.m. - Registration 8:00 a.m. - Panel 10:00 a.m. - Networking Reception WHERE: Wilmer Cutler Pickering Hale and Dorr, LLP 60 State Street, Boston, MA
To register for this event, please send contact information to email@example.com. Cost for members is $40; non-members, $80. To receive a press pass, please contact Shannon Altimari at 617-520-7250 or firstname.lastname@example.org.
The NEBATA Pipeline Series is made possible through sponsorship by Wilmer Cutler Pickering Hale and Dorr, LLP, Computer Associates and New Tilt.